Phase II Feasibility Study of Lipidiol Markers for Radiation Therapy Localisation and Response Assessment in the Multi-Disciplinary Team Management of Oesophageal-Gastric Cancer
Phase 2
- Conditions
- Oesophageal-gastric cancerCancer - StomachCancer - Oesophageal (gullet)
- Registration Number
- ACTRN12613000239763
- Lead Sponsor
- Austin Health
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot yet recruiting
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Biopsy-proven primary (non-recurrent) squamous cell carcinoma or adenocarcinoma of the oesophagus or stomach
Expected survival of at least 3 months
Age greater than 18 years
Medically suitable for radiotherapy
Written informed consent
Exclusion Criteria
Contraindications to CT contrast e.g. severe chronic kidney disease, allergy to contrast
Contraindications to PET/CT e.g. claustrophobia
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method